Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Symptom Collection of Lung Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03384680
Recruitment Status : Unknown
Verified January 2018 by Seong-Gyu Ko, Kyunghee University Medical Center.
Recruitment status was:  Recruiting
First Posted : December 27, 2017
Last Update Posted : January 9, 2018
Sponsor:
Information provided by (Responsible Party):
Seong-Gyu Ko, Kyunghee University Medical Center

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study is conducted to collect the symptoms of lung cancer patients and to observe the relationship with proteomics.

Condition or disease
Lung Cancer

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Study on Symptom Collection of Patients With Lung Cancer.
Actual Study Start Date : September 16, 2015
Estimated Primary Completion Date : March 31, 2018
Estimated Study Completion Date : May 31, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lung Cancer

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Pattern identification [ Time Frame: For 1 year ]

    Pattern identification by Body constitution questionnaire(BCQ) BCQ(+) is a questionnaire that is comprised of nineteen questions with one-to-five rating scales, making the range of total score to be between nineteen and ninety-five points with the cut-off score of 30.5 points for Yang-Xu.

    BCQ(-) is composed of another set of nineteen questions with the same five-point Likert scales, with the cut-off score of 29.5 points for Yin-Xu.

    BCQ(s) consists of twenty-three questions with the same Likert scale cut-off score of 26.5 points for Stasis.



Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with lung cancer who are scheduled for surgery will be enrolled.
Criteria

Inclusion Criteria:

  • Adult over 18 years old
  • Patients are scheduled for surgery with lung cancer diagnosis.
  • ECOG status score 0 to 2
  • Individual who can read and understand Korean
  • Participant is willing and able to give informed consent for participation in the study

Exclusion Criteria:

  • Patient who was diagnosed with lung cancer in the past.
  • Individuals who are judged inappropriate for the study
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03384680


Contacts
Layout table for location contacts
Contact: Chunhoo Cheon 02-961-9278 pm.thehoo@gmail.com

Locations
Layout table for location information
Korea, Republic of
Korea University Guro Hospital Recruiting
Seoul, Korea, Republic of
Contact: Hyjin Son         
Sponsors and Collaborators
Seong-Gyu Ko
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Seong-Gyu Ko, Prof., Kyunghee University Medical Center
ClinicalTrials.gov Identifier: NCT03384680    
Other Study ID Numbers: KCRD_Lung cancer_Symptoms
First Posted: December 27, 2017    Key Record Dates
Last Update Posted: January 9, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
 Neoplasms
Lung Diseases
Respiratory Tract Diseases